We are live on ! Find out more
Qube Research & Technologies (QRT)

Qube Research & Technologies (QRT) Portfolio holdings

AUM $89.9B
1-Year Est. Return 20.22%
This Fund
S&P 500
This Quarter Est. Return
+6.9%
1 Year Est. Return
+20.22%
3 Year Est. Return
+42.42%
5 Year Est. Return
+23.97%
10 Year Est. Return
AUM
$98.4B
AUM Growth
+$12.2B
Cap. Flow
+$4.67B
Cap. Flow %
4.75%
Top 10 Hldgs %
7.81%
Holding
4,101
New
656
Increased
1,629
Reduced
1,101
Closed
596

Sector Composition

Rank Sector Weight
1 Technology 13.24%
2 Financials 10.53%
3 Industrials 10.31%
4 Healthcare 10.01%
5 Consumer Discretionary 9.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KMX icon
251
CarMax
KMX
$8.27B
$101M 0.1%
+1,504,048
New +$101M
LYFT icon
252
Lyft
LYFT
$5.39B
$101M 0.1%
6,394,330
+5,453,915
+580% +$76.4M
LRCX icon
253
PUT
Lam Research
LRCX
$382B
$101M 0.1%
1,034,000
-349,900
-25% -$27.8M
CTSH icon
254
Cognizant
CTSH
$21.5B
$100M 0.1%
1,285,162
+19,917
+2% +$1.53M
MSTR icon
255
PUT
Strategy Inc
MSTR
$33.5B
$100M 0.1%
247,600
-170,700
-41% -$62.2M
TSN icon
256
Tyson Foods
TSN
$20.2B
$100M 0.1%
1,789,133
-365,751
-17% -$21M
PHM icon
257
Pultegroup
PHM
$24.5B
$99.8M 0.1%
946,555
-19,776
-2% -$1.99M
MRK icon
258
CALL
Merck
MRK
$324B
$99.3M 0.1%
1,254,000
+982,000
+361% +$78.1M
AVY icon
259
Avery Dennison
AVY
$12.3B
$98.4M 0.1%
560,863
-121,723
-18% -$21.3M
ABBV icon
260
PUT
AbbVie
ABBV
$458B
$98.2M 0.1%
529,200
+150,500
+40% +$28M
ED icon
261
Consolidated Edison
ED
$41.6B
$98.2M 0.1%
978,160
+935,463
+2,191% +$99M
HRB icon
262
H&R Block
HRB
$5.18B
$96.1M 0.1%
1,750,760
+312,776
+22% +$18.1M
EHC icon
263
Encompass Health
EHC
$11.2B
$96M 0.1%
783,103
+251,037
+47% +$28.7M
MRK icon
264
PUT
Merck
MRK
$324B
$96M 0.1%
1,212,600
+171,600
+16% +$13.6M
VRSN icon
265
VeriSign
VRSN
$25.3B
$94.2M 0.1%
326,246
+154,551
+90% +$41.9M
WCN
266
Waste Connections
WCN
$42.8B
$93.8M 0.1%
502,151
+229,648
+84% +$44.2M
URBN icon
267
Urban Outfitters
URBN
$5.99B
$93.4M 0.09%
1,287,096
+477,909
+59% +$28.7M
KO icon
268
PUT
Coca-Cola
KO
$354B
$93.4M 0.09%
1,319,600
-35,200
-3% -$2.51M
BIIB icon
269
Biogen
BIIB
$29.9B
$93.4M 0.09%
743,309
-483,400
-39% -$60.2M
CTVA icon
270
Corteva
CTVA
$59.7B
$92.9M 0.09%
1,247,120
+1,059,872
+566% +$70.6M
HAL icon
271
Halliburton
HAL
$27.9B
$92.9M 0.09%
4,559,755
-3,481,659
-43% -$73M
WFC icon
272
PUT
Wells Fargo
WFC
$261B
$92.9M 0.09%
1,159,500
+107,700
+10% +$7.77M
IJR icon
273
iShares Core S&P Small-Cap ETF
IJR
$109B
$92.6M 0.09%
847,352
+614,785
+264% +$63.6M
COST icon
274
CALL
Costco
COST
$415B
$92.4M 0.09%
93,300
+18,200
+24% +$18.1M
BX icon
275
PUT
Blackstone
BX
$104B
$92M 0.09%
615,200
-286,100
-32% -$39.3M

Similar funds

Qube Research & Technologies (QRT)'s Q2 2025 Portfolio in Review

As of Q2 2025, Qube Research & Technologies (QRT) held 4,101 positions worth $98.4B, up 14% from $86.2B the previous quarter. Its ten largest holdings account for 7.8% of the portfolio.

Qube Research & Technologies (QRT) deployed $4.67B of net new capital in Q2 2025, opening 656 new positions and adding to 1,629 existing holdings. Its largest new stake was Bristol-Myers Squibb: 9,752,683 shares worth $451M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 15% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $675M trimmed.

  • Qube Research & Technologies (QRT)'s largest Q2 2025 buy was Bristol-Myers Squibb: 9,752,683 shares worth $451M.
  • Qube Research & Technologies (QRT) added most to Thermo Fisher Scientific in Q2 2025, an estimated $486M increase.
  • Qube Research & Technologies (QRT)'s biggest Q2 2025 reduction was Meta Platforms (Facebook), cutting an estimated $675M.
  • Qube Research & Technologies (QRT) fully exited Broadcom in Q2 2025, selling an estimated $1.02B.
  • Qube Research & Technologies (QRT)'s ten largest holdings make up 7.8% of its $98.4B portfolio in Q2 2025.
  • Qube Research & Technologies (QRT) opened 656 new positions and closed 596 in Q2 2025.
  • Qube Research & Technologies (QRT)'s portfolio value rose 14% quarter-over-quarter to $98.4B.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2025, filed 14 Aug 2025.